Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold

被引:39
|
作者
Zhao, Ailing [2 ]
Gao, Xin [1 ]
Wang, Yuanxiang [2 ]
Ai, Jing [1 ]
Wang, Ying [1 ]
Chen, Yi [1 ]
Geng, Meiyu [1 ]
Zhang, Ao [2 ]
机构
[1] Chinese Acad Sci, SIMM, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, SIMM, State Key Lab Drug Res, SOMCL, Shanghai 201203, Peoples R China
关键词
RTK; c-Met; Thieno[2,3-d]pyrimidine; Furo[2,3-d]pyrimidine; Antitumor; FACTOR SCATTER FACTOR; TYROSINE KINASE; BIOLOGICAL EVALUATION; SELECTIVE INHIBITORS; GROWTH; POTENT; PHENOTYPE; CELLS; IDENTIFICATION; METASTASIS;
D O I
10.1016/j.bmc.2011.05.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of thieno[2,3-d]pyrimidines and furo[2,3-d] pyrimidines were synthesized and evaluated for the c-Met inhibition. Thieno[2,3-d]pyrimidine 6b stood out as the most potent showing an IC(50) of 35.7 nM. This compound displayed high inhibitory effect on cell proliferation in BaF3-TPR-Met cells and showed high selectivity for c-Met family against other 14 tested kinases. However, compound 6b was found ineffective in the c-Met-dependent U-87MG human gliobastoma xenograft model that may be relevant to its poor PK profile. (C) 2011 Elsevier Ltd. All rights
引用
收藏
页码:3906 / 3918
页数:13
相关论文
共 50 条
  • [1] Discovery of novel Bruton's tyrosine kinase (BTK) inhibitors bearing a pyrrolo[2,3-d]pyrimidine scaffold
    Zhao, Xinge
    Huang, Wei
    Wang, Yazhou
    Xin, Minhang
    Jin, Qiu
    Cai, Jianfeng
    Tang, Feng
    Zhao, Yong
    Xiang, Hua
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (04) : 891 - 901
  • [2] PYRIDO[2,3-D]PYRIMIDINE AND PYRANO[2,3-D]PYRIMIDINE
    CHUIGUK, VA
    PINCHUK, NA
    UKRAINSKII KHIMICHESKII ZHURNAL, 1982, 48 (10): : 1112 - 1113
  • [3] Synthesis and antifolate activity of new pyrrolo[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine inhibitors of dihydrofolate reductase
    Vaidya, C
    Wright, JE
    Rosowsky, A
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2004, 41 (05) : 787 - 793
  • [4] Design, synthesis, and biological evaluation of thieno[2,3-d]pyrimidine derivatives as novel dual c-Met and VEGFR-2 kinase inhibitors
    Li, Jieming
    Gu, Weijie
    Bi, Xinzhou
    Li, Huilan
    Liao, Chen
    Liu, Chunxia
    Huang, Wenlong
    Qian, Hai
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (24) : 6674 - 6679
  • [5] Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
    Aziz, Marwa A.
    Serya, Rabah A. T.
    Lasheen, Deena S.
    Abouzid, Khaled A. M.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 2 (01) : 1 - 8
  • [6] Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents
    Elrazaz, Eman Z.
    Serya, Rabah A. T.
    Ismail, Nasser S. M.
    Abou El Ella, Dalal A.
    Abouzid, Khaled A. M.
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 1 (02) : 33 - 41
  • [7] Hit Selection of Dipeptidyl Peptidase-4 Inhibitors Bearing Thieno[2,3-d]Pyrimidine Scaffold
    Pavlovic, Katarina Tomovic
    Ilic, Budimir S.
    Dimov, Stefan
    Yancheva, Denitsa
    Mavrova, Anelia Ts
    Smelcerovic, Andrija
    CHEMISTRY & BIODIVERSITY, 2025,
  • [8] SYNTHESIS OF NOVEL THIENO[2,3-D]PYRIMIDINE, THIENO[2,3-B]PYRIDINE AND THIAZOLO[3,2-A]THIENO[2,3-D]PYRIMIDINE DERIVATIVES AND THEIR EFFECT ON THE PRODUCTION OF MYCOTOXINS
    ABDELRAZEK, FM
    SALAH, AM
    ELBAZZA, ZE
    ARCHIV DER PHARMAZIE, 1992, 325 (05) : 301 - 305
  • [9] STUDIES ON 4-CHLOROPYRIDO[2,3-D]PYRIMIDINE AND PYRIDO[2,3-D]PYRIMIDINE
    HIGASHINO, T
    HAYASHI, E
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1970, 18 (07) : 1457 - +
  • [10] Synthesis, biological activity, and in silico studies of thieno[2,3-d]pyrimidine and thieno[2,3-d]triazine derivatives
    El-Hag, Fatma A. A.
    Elrashedy, Ahmed A.
    Sweed, Ayman M. K.
    Ewies, Ewies F.
    Abd-El-Maksoud, Mansoura A.
    Aly, Magdy S.
    Atta, Sanaa M. Sh.
    EGYPTIAN PHARMACEUTICAL JOURNAL, 2022, 21 (03) : 360 - 375